[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368830-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368830-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","functional-characterization-and-clinical-significance-of-igsf8-in-pan-cancer-an-integrated-bioinformatic-and-experimental-study","Functional characterization and clinical signiﬁcance of IGSF8 in pan-cancer - an integrated bioinformatic and experimental study","","Immunoglobulin superfamily member 8 (IGSF8) is examined for its biological functions and clinical relevance across multiple cancer types using an integrated bioinformatic and experimental framework. Public databases are leveraged to quantify expression, mutation status, prognosis, tumor heterogeneity, stemness, immune checkpoint associations, and immune-cell infiltration. Drug sensitivity is assessed with GDSC and CTRP resources, while functional validation uses CCK8 and colony formation assays. Results indicate elevated IGSF8 in numerous cancers, links to worse outcomes, immune regulatory and CD276 correlations, and growth inhibition after IGSF8 knockdown.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/functional-characterization-and-clinical-significance-of-igsf8-in-pan-cancer-an-integrated-bioinformatic-and-experimental-study/368830/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/functional-characterization-and-clinical-significance-of-igsf8-in-pan-cancer-an-integrated-bioinformatic-and-experimental-study/368830.png","ImageObject",300,407,{"name":42,"@type":43},"Elsa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central focus of the study on IGSF8 in pan-cancer?","Question",{"text":63,"@type":64},"The study investigates IGSF8’s biological roles and evaluates its clinical significance across diverse cancer types, including links to prognosis and tumor microenvironment features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which methods and databases were used to study IGSF8?",{"text":68,"@type":64},"Public pan-cancer databases were used to analyze expression, mutations, prognosis, heterogeneity, stemness, immune checkpoint genes, and immune-cell infiltration. GDSC and CTRP were used for drug sensitivity, and CCK8 and colony formation assays tested effects on cancer cell growth.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings support IGSF8 as a potential biomarker or target?",{"text":72,"@type":64},"IGSF8 is upregulated in many cancers, correlates with poor prognosis in certain cancers, shows associations with immune regulatory and checkpoint genes (including positive correlation with CD276), and IGSF8 knockdown inhibits proliferation of prostate cancer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368830,1790478588,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Original Research PUBLISHED 27 August 2025  \nDOI 10.3389/fimmu.2025.1642193  \nOPEN ACCESS  \nEDITED BY  \nWei Chong,  \nShandong Provincial Hospital, China  \nREVIEWED BY  \nYanxu Chen,  \nUniversity of Oxford, United Kingdom Hengrui Liu,  \nUniversity of Cambridge, United Kingdom Zhang Jianye,  \nPeking University, China  \n*CORRESPONDENCE  \nDechao Feng  \n [dechao.feng@ucl.ac.uk](dechao.feng@ucl.ac.uk)[ ](dechao.feng@ucl.ac.uk)Luxia Ye  \n[ylx941016@163.com](ylx941016@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 06 June 2025  \nACCEPTED 04 August 2025  \nPUBLISHED 27 August 2025  \nCITATION  \nWang J, Lu L, Wu R, Li D, Wang Z, Ye L and Feng D (2025) Functional characterization and clinical signiﬁcance of IGSF8 in pan-cancer: an integrated bioinformatic and experimental study.  \nFront. Immunol. 16:1642193 .  \ndoi: 10.3389/fimmu.2025.1642193  \nCOPYRIGHT  \n© 2025 Wang, Lu, Wu, Li, Wang, Ye and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nFunctional characterization and clinical signiﬁcance of IGSF8 in pan-cancer: an integrated bioinformaticand experimental study  \nJie Wang 1,2†, Lingxiao Lu 3†, Ruicheng Wu 1,2†, Dengxiong Li 1,2, Zhipeng Wang 4, Luxia Ye 3* and Dechao Feng 1,2,5*  \n1 Department of Urology, The First Afﬁliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China, 2 Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China, 3 Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Afﬁliated to Wenzhou Medical University, Linhai, China, 4 Department of Urology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China, 5 Division of Surgery and Interventional Science, University College London, London, United Kingdom  \nBackground: Immunoglobulin superfamily member 8 (IGSF8) is a membrane protein implicated in crucial biological processes like cell interactions and immune responses. Emerging evidence suggests that IGSF8 plays a signiﬁcant role in various cancers by inﬂuencing tumor progression through regulation of cell proliferation, migration, and apoptosis. Analyzing its expression, mutation status, and clinical correlations across different cancer types through pan-cancer bioinformatics could provide valuable insights into its potential as a biomarker and target for cancer therapies.  \nMethods: In this study, we utilized several public databases to investigate the biological role of IGSF8, focusing on its associations with prognosis, tumor heterogeneity, stemness, immune checkpoint genes, and immune cell inﬁltration across different types of cancer. Additionally, the GDSC and CTRP databases were employed to assess the sensitivity of IGSF8 to small molecule drugs. CCK8 assay and colony formation assay were used to detect its biological effect on cancer cells.  \nResults: IGSF8 was signiﬁcantly upregulated in 23 types of cancers and associated with poor prognosis in several cancers, including cell carcinoma and endocervical adenocarcinoma (CESC) and Acute Myeloid Leukemia(LAML) . Its high expression was linked to multiple immune regulatory genes and immune checkpoint genes in the tumor microenvironment, with a notable positive correlation with CD276 in most cancers. IGSF8 was also closely associated with multiple indicators of tumor heterogeneity, stemness, as well assigniﬁcant RNA methylation modiﬁcations across various cancers . Drug sensitivity analysis identiﬁed BX-795 and tozasertib as potential t","cbCaisyGLbhofIe6","https://ap.wps.com/l/cbCaisyGLbhofIe6","pdf",20795006,15,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What is the central focus of the study on IGSF8 in pan-cancer?\",\"answer\":\"The study investigates IGSF8’s biological roles and evaluates its clinical significance across diverse cancer types, including links to prognosis and tumor microenvironment features.\"},{\"question\":\"Which methods and databases were used to study IGSF8?\",\"answer\":\"Public pan-cancer databases were used to analyze expression, mutations, prognosis, heterogeneity, stemness, immune checkpoint genes, and immune-cell infiltration. GDSC and CTRP were used for drug sensitivity, and CCK8 and colony formation assays tested effects on cancer cell growth.\"},{\"question\":\"What key findings support IGSF8 as a potential biomarker or target?\",\"answer\":\"IGSF8 is upregulated in many cancers, correlates with poor prognosis in certain cancers, shows associations with immune regulatory and checkpoint genes (including positive correlation with CD276), and IGSF8 knockdown inhibits proliferation of prostate cancer cells.\"}]","Functional characterization and clinical signiﬁcance of IGSF8 in pan-cancer - an integrated bioinformatic and experimental study | PDF",1790178859,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/876d66fc018df87cf5a1280e299e7cdc.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92667d39fadc15f8f5d57140ea032489.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99453273737e4b06170a290a47de2145.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/512dbae2d4f462cedacfb728bbfe3a28.webp",980,1385]